跳至主要内容
临床试验/NCT05453591
NCT05453591招募中不适用

Investigation of Urinary Biomarkers for the Detection of Breast Cancer

Novosanis NV2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年12月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Novosanis NV
入组人数
200
试验地点
2
主要终点
Detection (presence/absence) of specific urinary biomarker targets (HER2, PIK3CA) for breast cancer patients measured using ddPCR.

研究概览

简要总结

The aim of this study is to investigate and possibly validate urinary biomarkers for breast cancer. During this study the focus will be on aberrations of selected genes as prognostic or predictive value has been shown for these genes in tissue, CTC or blood derived cfDNA. Proteins will be explored in urine as well.

This is a prospective study in which urine samples will be collected from healthy volunteers and urine samples and a blood sample from cancer patients with breast cancer. The participants will be asked to provide a urine sample collected with the ColliPee® device and fill out an online questionnaire to collect usability data. Thereafter, the urine sample will be aliquoted to be used in the study to investigate the different urinary analytes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Being at least 18 years old
  • Being able to understand and read Dutch
  • For cancer patients: diagnosed with breast cancer

排除标准

  • For cancer patients: suffering from a blood cancer
  • For healthy volunteers: diagnosed with cancer

结局指标

主要结局

Detection (presence/absence) of specific urinary biomarker targets (HER2, PIK3CA) for breast cancer patients measured using ddPCR.

时间窗: Through study completion, an average of 1 year.

Comparison of target detection measured using ddPCR assays \[positive, negative or copies/µL\] in first-void urine samples from breast cancer patients compared to age- and sex-matched healthy volunteers. (Proof of concept study)

次要结局

  • Detection (presence/absence) of specific biomarker targets (HER2, PIK3CA) for breast cancer patients measured using ddPCR.(Through study completion, an average of 1 year)
  • Usability characteristics of the Colli-Pee UAS devices.(Through study completion, an average of 1 year)

研究者

发起方
Novosanis NV
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Investigation of Urinary Biomarkers for the... | 临床试验